IPR's Affiliated Reports Collection Announces Competitor Analysis Report

Competitor Analysis: Malaria Vaccines and Therapeutics Report
By: Insight Pharma Reports
Jan. 16, 2013 - PRLog -- NEEDHAM, MASS. – Cambridge Healthtech Institute’s Insight Pharma Reports Affiliated Reports Collection announces the Competitor Analysis: Malaria Vaccines and Therapeutics Report.

Malaria is a mosquito-borne infectious disease caused by the Plasmodium parasite, especially Pl. falciparum. The parasite is transfected by the bite of a mosquito. Malaria is widespread in tropical and subtropical regions. Each year more than 350 million new cases of Malaria occur, it is one of the world’s most common diseases. People with malaria often experience fever, chills, and flu-like illness. Left untreated, they may develop severe complications and die. Non-profit organizations play a major role in supporting the discovery and development of novel vaccines to fight malaria. Industry partners are sought for production of the vaccine and to provide adjuvants if appropriate.

The present Competitive Intelligence Report about Malaria Vaccines & Therapeutics provides a competitor evaluation in the field of investigational small molecules and biologics to treat or prevent malaria and of vaccines against one or more antigens of the Plasmodium (Pl) parasite, especiall of Pl. falciparum, for prophylaxis of Malaria as of August 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.  

The report includes a compilation of currently active projects in development of small molecules and biologics as malaria therapeutics and of vaccines targeting antigens of the Plasmodium parasite for prophylaxis of Malaria.

Read more about this report online at:  http://www.insightpharmareports.com/Affiliated-Reports/LaMerie/Competitor-Analysis--Malaria-Vaccines---Therapeutics/

For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com or contact Kerri Simpson at ksimpson@healthtech.com or 781-972-1347.

About Insight Pharma Reports

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute.  http://www.InsightPharmaReports.com

Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/affiliatedreports/
Email:***@healthtech.com Email Verified
Tags:Insight Pharma Reports, Chi, Malaria, Pharma Reports, Biotech
Industry:Biotech, Reports
Location:Needham - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Insight Pharm Reports News
Most Viewed
Daily News

Like PRLog?
Click to Share